Fidelity Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $591M | Buy |
|
|||||
|
2025
Q2 | $406M | Buy |
|
|||||
|
2025
Q1 | $471M | Buy |
|
|||||
|
2024
Q4 | $456M | Buy |
|
|||||
|
2024
Q3 | $228M | Buy |
|
|||||
|
2024
Q2 | $183M | Sell |
|
|||||
|
2024
Q1 | $209M | Buy |
|
|||||
|
2023
Q4 | $144M | Buy |
|
|||||
|
2023
Q3 | $63.7M | Buy |
|
|||||
|
2023
Q2 | $19.5M | Buy |
|
|||||
|
2023
Q1 | $14.8M | Sell |
|
|||||
|
2022
Q4 | $34.5M | Sell |
|
|||||
|
2022
Q3 | $52.7M | Sell |
|
|||||
|
2022
Q2 | $55.7M | Sell |
|
|||||
|
2022
Q1 | $73.3M | Sell |
|
|||||
|
2021
Q4 | $106M | Sell |
|
|||||
|
2021
Q3 | $93.2M | Sell |
|
|||||
|
2021
Q2 | $96.5M | Buy |
|
|||||
|
2021
Q1 | $75.5M | Sell |
|
|||||
|
2020
Q4 | $69.7M | Buy |
|
|||||
|
2020
Q3 | $77.3M | Buy |
|
|||||
|
2020
Q2 | $86.3M | Buy |
|
|||||
|
2020
Q1 | $50.5M | Sell |
|
|||||
|
2019
Q4 | $91.2M | Buy |
|
|||||
|
2019
Q3 | $54.5M | Buy |
|
|||||
|
2019
Q2 | $90.5M | Buy |
|
|||||
|
2019
Q1 | $82.3M | Buy |
|
|||||
|
2018
Q4 | $88.1M | Buy |
|
|||||
|
2018
Q3 | $77.9M | Buy |
|